TickerFactsScreenerDevelopers

Niagen Bioscience, Inc. (NAGE) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2011: $5.64M2012: $9.34M2013: $7.03M2015: $9.99M2016: $11.27M2017: $10.72M2018: $15.50M2019: $20.52M2020: $23.98M2021: $25.96M2022: $29.25M2023: $32.79M2024: $38.01M2025: $46.23M$46.23M
2011Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$46.23M+21.6%
2024$38.01M+15.9%
2023$32.79M+12.1%
2022$29.25M+12.7%
2021$25.96M+8.2%
2020$23.98M+16.9%
2019$20.52M+32.4%
2018$15.50M+44.6%
2017$10.72M-4.9%
2016$11.27M+12.9%
2015$9.99M—
2013$7.03M-24.7%
2012$9.34M+65.5%
2011$5.64M—